Price Alert

Revelation Biosciences In... (REVB)

NASDAQ: REVB · Real-Time Price · USD

2.87

0.07 (2.50%)

At close: Sep 05, 2025, 3:59 PM

2.92

1.57%

After-hours: Sep 05, 2025, 07:57 PM EDT

2.50% (1D)

Bid	2.73
Market Cap	4.88M
Revenue (ttm)	26.96K
Net Income (ttm)	-8.46M
EPS (ttm)	866.22
PE Ratio (ttm)	n/a
Forward PE	-0.38
Analyst	n/a

Ask	3
Volume	84,584
Avg. Volume (20D)	176,543
Open	2.87
Previous Close	2.80
Day's Range	2.75 - 2.88
52-Week Range	2.11 - 60.48
Beta	-0.04

About REVB

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol REVB

Website n/a

Full Company Profile

Why Price Moved

3 months ago

-54.4%

Revelation Biosciences shares are trading lower af... Unlock content with Pro Subscription

7 months ago

-23.84%

Revelation Biosciences shares are trading lower after the company announced plans for a 1-for-16 reverse stock split.

News

4 weeks ago · businesswire.com

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2025

SAN DIEGO--(BUSINESS WIRE)---- $REVB #AKI--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing inflammati...

1 month ago · businesswire.com

Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study

SAN DIEGO--(BUSINESS WIRE)---- $REVB #AKI--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company focused on rebalancing inflammation to op...

2 months ago · businesswire.com

Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025

SAN DIEGO--(BUSINESS WIRE)---- $REVB #AKI--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that, on July 7, 2025, the Company will implement a 1-for-3 reve...